R-Spondin1/LGR5 activates TGFβ signaling and suppresses colon cancer metastasis

Xiaolin Zhou, Liying Geng, Degeng Wang, Haowei Yi, Geoffrey A Talmon, Jing Wang

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Leucine-rich repeat containing G-protein–coupled receptor 5 (LGR5), an intestinal stem cell marker, is known to exhibit tumor suppressor activity in colon cancer, the mechanism of which is not understood. Here we show that R-spondin 1 (RSPO1)/LGR5 directly activates TGFb signaling cooperatively with TGFb type II receptor in colon cancer cells, enhancing TGFb-mediated growth inhibition and stress-induced apoptosis. Knockdown of LGR5 attenuated downstream TGFb signaling and increased cell proliferation, survival, and metastasis in an orthotopic model of colon cancer in vivo. Upon RSPO1 stimulation, LGR5 formed complexes with TGFb receptors. Studies of patient specimens indicate that LGR5 expression was reduced in advanced stages and positively correlated with markers of TGFb activation in colon cancer. Our study uncovers a novel cross-talk between LGR5 and TGFβ signaling in colon cancer and identifies LGR5 as a new modulator of TGFβ signaling able to suppress colon cancer metastasis.

Original languageEnglish (US)
Pages (from-to)6589-6602
Number of pages14
JournalCancer Research
Volume77
Issue number23
DOIs
StatePublished - Dec 1 2017

Fingerprint

Leucine
Colonic Neoplasms
Neoplasm Metastasis
Cell Survival
Stem Cells
Cell Proliferation
Apoptosis
Growth
Neoplasms

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

R-Spondin1/LGR5 activates TGFβ signaling and suppresses colon cancer metastasis. / Zhou, Xiaolin; Geng, Liying; Wang, Degeng; Yi, Haowei; Talmon, Geoffrey A; Wang, Jing.

In: Cancer Research, Vol. 77, No. 23, 01.12.2017, p. 6589-6602.

Research output: Contribution to journalArticle

Zhou, Xiaolin ; Geng, Liying ; Wang, Degeng ; Yi, Haowei ; Talmon, Geoffrey A ; Wang, Jing. / R-Spondin1/LGR5 activates TGFβ signaling and suppresses colon cancer metastasis. In: Cancer Research. 2017 ; Vol. 77, No. 23. pp. 6589-6602.
@article{10fd0f750c6b489e93d45a2501385161,
title = "R-Spondin1/LGR5 activates TGFβ signaling and suppresses colon cancer metastasis",
abstract = "Leucine-rich repeat containing G-protein–coupled receptor 5 (LGR5), an intestinal stem cell marker, is known to exhibit tumor suppressor activity in colon cancer, the mechanism of which is not understood. Here we show that R-spondin 1 (RSPO1)/LGR5 directly activates TGFb signaling cooperatively with TGFb type II receptor in colon cancer cells, enhancing TGFb-mediated growth inhibition and stress-induced apoptosis. Knockdown of LGR5 attenuated downstream TGFb signaling and increased cell proliferation, survival, and metastasis in an orthotopic model of colon cancer in vivo. Upon RSPO1 stimulation, LGR5 formed complexes with TGFb receptors. Studies of patient specimens indicate that LGR5 expression was reduced in advanced stages and positively correlated with markers of TGFb activation in colon cancer. Our study uncovers a novel cross-talk between LGR5 and TGFβ signaling in colon cancer and identifies LGR5 as a new modulator of TGFβ signaling able to suppress colon cancer metastasis.",
author = "Xiaolin Zhou and Liying Geng and Degeng Wang and Haowei Yi and Talmon, {Geoffrey A} and Jing Wang",
year = "2017",
month = "12",
day = "1",
doi = "10.1158/0008-5472.CAN-17-0219",
language = "English (US)",
volume = "77",
pages = "6589--6602",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "23",

}

TY - JOUR

T1 - R-Spondin1/LGR5 activates TGFβ signaling and suppresses colon cancer metastasis

AU - Zhou, Xiaolin

AU - Geng, Liying

AU - Wang, Degeng

AU - Yi, Haowei

AU - Talmon, Geoffrey A

AU - Wang, Jing

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Leucine-rich repeat containing G-protein–coupled receptor 5 (LGR5), an intestinal stem cell marker, is known to exhibit tumor suppressor activity in colon cancer, the mechanism of which is not understood. Here we show that R-spondin 1 (RSPO1)/LGR5 directly activates TGFb signaling cooperatively with TGFb type II receptor in colon cancer cells, enhancing TGFb-mediated growth inhibition and stress-induced apoptosis. Knockdown of LGR5 attenuated downstream TGFb signaling and increased cell proliferation, survival, and metastasis in an orthotopic model of colon cancer in vivo. Upon RSPO1 stimulation, LGR5 formed complexes with TGFb receptors. Studies of patient specimens indicate that LGR5 expression was reduced in advanced stages and positively correlated with markers of TGFb activation in colon cancer. Our study uncovers a novel cross-talk between LGR5 and TGFβ signaling in colon cancer and identifies LGR5 as a new modulator of TGFβ signaling able to suppress colon cancer metastasis.

AB - Leucine-rich repeat containing G-protein–coupled receptor 5 (LGR5), an intestinal stem cell marker, is known to exhibit tumor suppressor activity in colon cancer, the mechanism of which is not understood. Here we show that R-spondin 1 (RSPO1)/LGR5 directly activates TGFb signaling cooperatively with TGFb type II receptor in colon cancer cells, enhancing TGFb-mediated growth inhibition and stress-induced apoptosis. Knockdown of LGR5 attenuated downstream TGFb signaling and increased cell proliferation, survival, and metastasis in an orthotopic model of colon cancer in vivo. Upon RSPO1 stimulation, LGR5 formed complexes with TGFb receptors. Studies of patient specimens indicate that LGR5 expression was reduced in advanced stages and positively correlated with markers of TGFb activation in colon cancer. Our study uncovers a novel cross-talk between LGR5 and TGFβ signaling in colon cancer and identifies LGR5 as a new modulator of TGFβ signaling able to suppress colon cancer metastasis.

UR - http://www.scopus.com/inward/record.url?scp=85037704300&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85037704300&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-17-0219

DO - 10.1158/0008-5472.CAN-17-0219

M3 - Article

C2 - 28939678

AN - SCOPUS:85037704300

VL - 77

SP - 6589

EP - 6602

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 23

ER -